Jordan Strom, ESC 2021 – Analysis of the Risks of Moderate and Lesser Aortic Stenosis
Dr Jordan Strom (Director of Echocardiographic Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) kindly shared his thoughts on his recent analysis of clinical trial and administrative claims data on patients with untreated aortic stenosis from the virtual ESC Congress 2021.
- What are the aims and scope of your current analysis of clinical trial and administrative claims data? (0.29)
- What were the findings of this analysis, and what are their implications for further study? (3.56)
- What will be the next steps in your research? (11.16)
Speaker disclosures: Dr Jordan Strom reports grant funding from Edwards Lifesciences for the discussed project. He also reports grant funding from Ultromics, HeartSciences, and Anumana, consulting for Bracco Diagnostics, and speaker fees from Northwest Imaging Forums, unrelated to the submitted work.
Support: Interview and filming supported by Touch Medical Media and conducted by Heather Hall.
Filmed during a remote video call with Dr Jordan Strom as a highlight of ESC 2021, August 2021.
Share this Video
Related Videos In Cardiovascular Disease
John Forrest, ACC 2023: Evolut low risk trial, transcatheter versus surgical aortic valve replacement in patients at low surgical risk
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
John Forrest, ACC 2023: The treatment paradigm for patients with aortic stenosis
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Steven Nissen, ACC 2023: Lipid-lowering therapies – current and future options
Many lipid-lowering therapies exist, such as statins to manage and reduce lipid levels. While statins are the most commonly used medication, some patients may need additional interventions to lower their LDL cholesterol levels. In this touchCARDIO interview, we speak with Prof. Steven Nissen (Cleveland Clinic, Cleveland, OH, USA) to explore current and developing novel lipid-lowering […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!